Generate an explanation for the given claim using the provided supporting material from the paragraph. Please consider the following points while generating an output. 1) The claim will always have supporting proof in the paragraph, and the paragraph will have a clear point of view supporting the claim. 2) There can be instances where direct correlation to the claim is not available. Make use of the sentences in the paragraph to provide a corresponding output supporting the claim. 3) The explanation should be at least one and at most twelve sentences long.

Ex Input:
Paragraph: Fitness experts say users of the fitness machine, which is a favorite among Army Rangers, Navy Seals, and “The Biggest Loser” television series, reap total body, calorie-busting rewards. “It’s a great and tough cardio piece,” said Neal Pire, an exercise physiologist with the American College of Sports Medicine. “Picture a step mill that combines the lower and upper body, and you have Jacobs Ladder. Except instead of steps, you have rungs.”  Because the user climbs with arms as well as legs more muscles are working and more calories are burned. “As a rule the more muscle mass you utilize during any activity, the greater the oxygen consumed, which is directly correlated to the calories you consumed,” said Pire, president of Inspire Training Systems, in New Jersey. “Unlike stair climbers, you can’t hold on to the sides.”  Jacobs Ladder was invented by Steve Nichols, a fitness champion who injured his knees and back, according to Bob Palka, president of Jacobs Ladder, LLC. “He wanted to come up with a good workout that didn’t impact back and knees.” said Palka, who bought the patent and assets from Nichols in 1994. “Effectively it’s just climbing a ladder,” Palka said. People using the machine are placed at a 40-degree angle to put the spine in a more neutral position, relieve the back of stress and engage core muscles. Palka said on Jacobs Ladder the person’s body weight is lifted over a 12-inch (30.5-centemeter) step for fuller range of motion than the eight-inches of a step mill. “You control the speed,” he said.” The faster you go the faster the runners (on the ladder) come.”  Palka said about 50 to 60 percent of his Jacobs Ladders go to health clubs; some 10 to 15 percent go to the military and physical therapy facilities, respectively. Jacobs Ladder landed a recurring role on the TV show “The Biggest Loser” after trainer Jillian Michaels fell in love with it. “It tends to get your heart rate up,” said Palka, adding that other users, such as the FBI and the Army Rangers, are drawn to the intensity of the workout. John Trail, general manager of a Fitness First health club in Arlington, Virginia, uses Jacobs Ladder in functional circuit and interval training. “You can go for time or you can go for feet,” said Trail. “It’s not a fast-moving piece, but the fact that you’re using every muscle group means you can do 100 feet, rest, jump off, do 10 kettlebell swings, 10 short interval sprints, and burn a lot more calories than you would on an elliptical.”  Trail said a rock climbing buddy likes to climb Jacobs Ladder wearing a back pack for an endurance workout. A self-described competitive person, Trail has even raced with it. “We have two machines side-by-side, so we’ll go for 1,000 feet as fast as possible,” he said. “In under 10 minutes you can get a really good workout.”  He also uses it on clients with joint issues to get their heart rates up quickly. But despite its virtues, Pire said it’s unlikely Jacobs Ladder will supplant the treadmill anytime soon. “The tougher the machine, the more seldom you see it,” he said. “I haven’t seen many seniors hop on. The older population is concerned about balance and falling. And there’s some skill involved in climbing a ladder. But fans are ardent. “Those who use it are almost religious,” he said. Claim: Jacobs Ladder climbers reap tough fitness rewards.

Ex Output:
Jacobs Ladder, a moving, angled, climbing machine, may be named after the Biblical stairway to heaven, but it packs such a challenging workout people have dubbed it the stairway to hell.


Ex Input:
Paragraph: The lawsuit marks the first multi-plaintiff trial in the litigation over whether glyphosate, Roundup’s active ingredient, is carcinogenic, and is the first trial outside of California. It is being held in St. Louis, where Monsanto was headquartered before Bayer bought the company in a $63 billion deal in 2018. Three consecutive juries found the company liable for causing cancer with damages of tens of millions of dollars awarded to each plaintiff. Bayer is appealing those verdicts. Court-appointed mediator Ken Feinberg has put the number of Roundup cancer claimants at more than 75,000 while Bayer said the claims it has been served with in court were below 50,000. Bayer’s share price has tumbled since the first verdict in August 2018 but the stock rose 3% on Friday after Bloomberg reported a possible out-of-court settlement with some plaintiffs that could lead to a total payout of about $10 billion. While traders said the market likes the idea of Bayer settling the litigation, some cautioned that the prospect of a comprehensive deal remained uncertain. Analysts have estimated the size of any such settlement at $8-$12 billion. While most plaintiffs’ lawyers have agreed to postpone trials pending negotiations, some have decided to pursue their clients’ day in court. The case in Missouri’s Circuit Court for the 22nd Judicial Circuit of the City of St. Louis is scheduled to last several weeks, with both sides presenting extensive scientific evidence through expert witnesses. Bayer denies all allegations that Roundup or glyphosate causes cancer, saying decades of independent studies have shown the world’s most widely used weed killer to be safe for human use and noting that regulators around the world have approved the product. “At the end of the day, this trial should come down to the weight of the science, and we remain confident in the extensive scientific record and regulatory assessments that support the safety of our glyphosate-based herbicides and that they do not cause cancer,” the company said in a statement. Several court cases have been postponed by both parties in the past to expedite settlement talks. By pursuing the St. Louis trail The Miller Firm LLC, a key player in the litigation, is seeking to increase pressure on Bayer. The case involves the claims of Bryce Batiste from Louisiana, Ann Meeks from Florida, Glen Ashelman from Pennsylvania and Christopher Wade, a St. Louis resident. All four have been diagnosed with non-Hodgkin’s lymphoma, a blood cell cancer that plaintiffs in the litigation allege is caused by Roundup. Some legal experts said Bayer could benefit from a home advantage in the St. Louis trial, where Monsanto has century-old roots. But juries in the city are also known to dole out massive damages awards against large corporations. Claim: Bayer faces fourth U.S. Roundup cancer trial in Monsanto's hometown.

Ex Output:
Bayer AG is set to face a fourth U.S. jury trial over allegations that its Roundup weed killer causes cancer, with four cancer patients in the hometown of its agricultural subsidiary Monsanto scheduled to begin making their case on Friday.


Ex Input:
Paragraph: Since the vaccine is not available, a discussion of costs is not warranted. The piece does a nice job of presenting the results of the initial report in terms of absolute and relative risk reduction; however, absolute data is not provided for the secondary analyses. To its credit, the story clearly and effectively explained statistical significance as it relates to this research. As stated in previous coverage, the story reiterates that the benefits of the vaccine are modest and additional research is needed. Given that this is a follow-up report focused on newly released data, a discussion of the potential harms of the vaccine is not necessary. This story does an excellent job defining the different types of analyses used to evaluate the outcome data. The story also points out the results of the secondary analyses have been published in a peer-reviewed journal, suggesting the calculations have been checked for accuracy. This story does not engage in disease-mongering. This story does not provide commentary from any independent sources. In this case, a single comment from a biostatistical consultant would have provided helpful perspective. Given the nature of this follow-up story, a discussion on the existing alternatives to HIV prevention may not be warranted. This story makes it known that the vaccine is still in the testing phase and is not yet available. The story makes it clear that researchers have been working on an AIDS vaccine for decades. The story does not appear to be based on a press release. Claim: AIDS Vaccine Is of Modest Help, Fuller Research Says

Ex Output:

This follow-up piece draws attention to secondary data analyses of the much talked about AIDS vaccination trial conducted in Thailand. According to the results released in September, the vaccine showed a statistically significant reduction in risk of HIV infection. However, two additional analyses published recently in the New England Journal of Medicine did not find statistical significance. This story underscores the need for healthy skepticism about early announcements of unpublished research. The writer did a nice job explaining different types of analysis and statistical significance, which many physicians and lay people have difficulty grasping.